Ketan Mehta provides examples of how he’s developed new therapies that address both regulatory concerns and patient needs.
Ketan Mehta
Advertisement
Ketan Mehta is founder and CEO of Tris Pharma.
Articles by Ketan Mehta
Tris Pharma CEO Ketan Mehta explains how addressing a drug’s impact can improve patient experience.
Ketan Mehta, CEO of Tris Pharma, explains how the company expanded its pipeline over the past two decades.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Beyond the Molecule: The New Competitive Battlefield in Oncology
2
FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax
3
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
4
Pharmaceutical Executive Daily: FDA Approves Beqalzi and Inqovi
5